nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisdexamfetamine—L-Lysine—SLC22A4—ulcerative colitis	0.0106	0.377	CrCbGaD
Lisdexamfetamine—SLC18A2—Synaptic Vesicle Pathway—PARK7—ulcerative colitis	0.00772	0.055	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Alpha-synuclein signaling—PARK7—ulcerative colitis	0.00685	0.0489	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Parkinsons Disease Pathway—PARK7—ulcerative colitis	0.00582	0.0415	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Adrenoceptors—ADRB2—ulcerative colitis	0.00578	0.0412	CbGpPWpGaD
Lisdexamfetamine—Amphetamine—SLC22A5—ulcerative colitis	0.00464	0.165	CrCbGaD
Lisdexamfetamine—SLC6A2—NRF2 pathway—SLC39A11—ulcerative colitis	0.00459	0.0327	CbGpPWpGaD
Lisdexamfetamine—Labetalol—ADRB2—ulcerative colitis	0.00446	0.159	CrCbGaD
Lisdexamfetamine—Methamphetamine—SLC22A5—ulcerative colitis	0.0043	0.153	CrCbGaD
Lisdexamfetamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—ulcerative colitis	0.00422	0.0301	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—ulcerative colitis	0.00422	0.0301	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—NRF2 pathway—SLC39A11—ulcerative colitis	0.00406	0.029	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	0.00326	0.0232	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—ulcerative colitis	0.00284	0.0203	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—ulcerative colitis	0.00284	0.0203	CbGpPWpGaD
Lisdexamfetamine—Lisinopril—ABCB1—ulcerative colitis	0.00263	0.0938	CrCbGaD
Lisdexamfetamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—ulcerative colitis	0.00263	0.0187	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—ulcerative colitis	0.00252	0.0179	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—ulcerative colitis	0.00252	0.0179	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—GPR35—ulcerative colitis	0.00224	0.016	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	0.00219	0.0156	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Monoamine GPCRs—ADRB2—ulcerative colitis	0.00205	0.0146	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—LPA receptor mediated events—GNA12—ulcerative colitis	0.00203	0.0144	CbGpPWpGaD
Lisdexamfetamine—Myocardial infarction—Methylprednisolone—ulcerative colitis	0.002	0.0024	CcSEcCtD
Lisdexamfetamine—Dry mouth—Mesalazine—ulcerative colitis	0.00198	0.00239	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Mesalazine—ulcerative colitis	0.00195	0.00234	CcSEcCtD
Lisdexamfetamine—SLC6A3—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	0.00194	0.0138	CbGpPWpGaD
Lisdexamfetamine—Hallucination—Hydrocortisone—ulcerative colitis	0.00194	0.00233	CcSEcCtD
Lisdexamfetamine—Visual impairment—Prednisolone—ulcerative colitis	0.00192	0.00231	CcSEcCtD
Lisdexamfetamine—SLC18A2—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	0.00192	0.0137	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	0.00192	0.0137	CbGpPWpGaD
Lisdexamfetamine—Nervous system disorder—Mesalazine—ulcerative colitis	0.00191	0.00229	CcSEcCtD
Lisdexamfetamine—Urticaria—Budesonide—ulcerative colitis	0.0019	0.00229	CcSEcCtD
Lisdexamfetamine—Tachycardia—Mesalazine—ulcerative colitis	0.0019	0.00228	CcSEcCtD
Lisdexamfetamine—Weight increased—Betamethasone—ulcerative colitis	0.00189	0.00227	CcSEcCtD
Lisdexamfetamine—Weight increased—Dexamethasone—ulcerative colitis	0.00189	0.00227	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Budesonide—ulcerative colitis	0.00189	0.00227	CcSEcCtD
Lisdexamfetamine—Skin disorder—Mesalazine—ulcerative colitis	0.00189	0.00227	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Mesalazine—ulcerative colitis	0.00188	0.00226	CcSEcCtD
Lisdexamfetamine—Weight decreased—Dexamethasone—ulcerative colitis	0.00188	0.00226	CcSEcCtD
Lisdexamfetamine—Weight decreased—Betamethasone—ulcerative colitis	0.00188	0.00226	CcSEcCtD
Lisdexamfetamine—Anorexia—Mesalazine—ulcerative colitis	0.00185	0.00223	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.00184	0.00222	CcSEcCtD
Lisdexamfetamine—Acute coronary syndrome—Dexamethasone—ulcerative colitis	0.00183	0.0022	CcSEcCtD
Lisdexamfetamine—Acute coronary syndrome—Betamethasone—ulcerative colitis	0.00183	0.0022	CcSEcCtD
Lisdexamfetamine—Hallucination—Methylprednisolone—ulcerative colitis	0.00182	0.00219	CcSEcCtD
Lisdexamfetamine—Eye disorder—Hydrocortisone—ulcerative colitis	0.00182	0.00219	CcSEcCtD
Lisdexamfetamine—Myocardial infarction—Dexamethasone—ulcerative colitis	0.00182	0.00218	CcSEcCtD
Lisdexamfetamine—Myocardial infarction—Betamethasone—ulcerative colitis	0.00182	0.00218	CcSEcCtD
Lisdexamfetamine—ADRA1B—G alpha (12/13) signalling events—GNA12—ulcerative colitis	0.00178	0.0127	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—ulcerative colitis	0.00177	0.0126	CbGpPWpGaD
Lisdexamfetamine—Visual impairment—Methylprednisolone—ulcerative colitis	0.00176	0.00212	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Budesonide—ulcerative colitis	0.00176	0.00212	CcSEcCtD
Lisdexamfetamine—Insomnia—Mesalazine—ulcerative colitis	0.00176	0.00212	CcSEcCtD
Lisdexamfetamine—Immune system disorder—Hydrocortisone—ulcerative colitis	0.00176	0.00211	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Mesalazine—ulcerative colitis	0.00173	0.00209	CcSEcCtD
Lisdexamfetamine—Somnolence—Mesalazine—ulcerative colitis	0.00173	0.00208	CcSEcCtD
Lisdexamfetamine—ADRA1B—Amine ligand-binding receptors—ADRB2—ulcerative colitis	0.00172	0.0123	CbGpPWpGaD
Lisdexamfetamine—Asthenia—Budesonide—ulcerative colitis	0.00172	0.00206	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Mesalazine—ulcerative colitis	0.00171	0.00206	CcSEcCtD
Lisdexamfetamine—Eye disorder—Methylprednisolone—ulcerative colitis	0.00171	0.00206	CcSEcCtD
Lisdexamfetamine—Mental disorder—Hydrocortisone—ulcerative colitis	0.00171	0.00205	CcSEcCtD
Lisdexamfetamine—Cardiac disorder—Methylprednisolone—ulcerative colitis	0.0017	0.00204	CcSEcCtD
Lisdexamfetamine—Malnutrition—Hydrocortisone—ulcerative colitis	0.0017	0.00204	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Mesalazine—ulcerative colitis	0.00169	0.00203	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Azathioprine—ulcerative colitis	0.00169	0.00203	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.00168	0.00202	CcSEcCtD
Lisdexamfetamine—Fatigue—Mesalazine—ulcerative colitis	0.00168	0.00202	CcSEcCtD
Lisdexamfetamine—Erectile dysfunction—Prednisone—ulcerative colitis	0.00167	0.002	CcSEcCtD
Lisdexamfetamine—Constipation—Mesalazine—ulcerative colitis	0.00166	0.002	CcSEcCtD
Lisdexamfetamine—Hallucination—Betamethasone—ulcerative colitis	0.00166	0.00199	CcSEcCtD
Lisdexamfetamine—Hallucination—Dexamethasone—ulcerative colitis	0.00166	0.00199	CcSEcCtD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.00165	0.0118	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—AMPK Signaling—HNF4A—ulcerative colitis	0.00165	0.0118	CbGpPWpGaD
Lisdexamfetamine—Immune system disorder—Methylprednisolone—ulcerative colitis	0.00165	0.00199	CcSEcCtD
Lisdexamfetamine—SLC18A2—Dopaminergic Neurogenesis—STAT3—ulcerative colitis	0.00165	0.0118	CbGpPWpGaD
Lisdexamfetamine—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.00165	0.00198	CcSEcCtD
Lisdexamfetamine—Weight increased—Prednisone—ulcerative colitis	0.00165	0.00198	CcSEcCtD
Lisdexamfetamine—Weight decreased—Prednisone—ulcerative colitis	0.00164	0.00197	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Budesonide—ulcerative colitis	0.00164	0.00197	CcSEcCtD
Lisdexamfetamine—Vision blurred—Prednisolone—ulcerative colitis	0.00164	0.00197	CcSEcCtD
Lisdexamfetamine—Depression—Prednisone—ulcerative colitis	0.00161	0.00194	CcSEcCtD
Lisdexamfetamine—Visual impairment—Dexamethasone—ulcerative colitis	0.0016	0.00193	CcSEcCtD
Lisdexamfetamine—Visual impairment—Betamethasone—ulcerative colitis	0.0016	0.00193	CcSEcCtD
Lisdexamfetamine—Mental disorder—Methylprednisolone—ulcerative colitis	0.0016	0.00193	CcSEcCtD
Lisdexamfetamine—Malnutrition—Methylprednisolone—ulcerative colitis	0.00159	0.00191	CcSEcCtD
Lisdexamfetamine—Acute coronary syndrome—Prednisone—ulcerative colitis	0.00159	0.00191	CcSEcCtD
Lisdexamfetamine—Angioedema—Prednisolone—ulcerative colitis	0.00159	0.00191	CcSEcCtD
Lisdexamfetamine—Myocardial infarction—Prednisone—ulcerative colitis	0.00158	0.0019	CcSEcCtD
Lisdexamfetamine—Dizziness—Budesonide—ulcerative colitis	0.00158	0.0019	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Azathioprine—ulcerative colitis	0.00157	0.00189	CcSEcCtD
Lisdexamfetamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—ulcerative colitis	0.00157	0.0112	CbGpPWpGaD
Lisdexamfetamine—Eye disorder—Dexamethasone—ulcerative colitis	0.00155	0.00187	CcSEcCtD
Lisdexamfetamine—Eye disorder—Betamethasone—ulcerative colitis	0.00155	0.00187	CcSEcCtD
Lisdexamfetamine—Angioedema—Hydrocortisone—ulcerative colitis	0.00155	0.00186	CcSEcCtD
Lisdexamfetamine—Urticaria—Mesalazine—ulcerative colitis	0.00155	0.00186	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Mesalazine—ulcerative colitis	0.00154	0.00185	CcSEcCtD
Lisdexamfetamine—SLC18A2—Dopaminergic Neurogenesis—TGFB1—ulcerative colitis	0.00153	0.0109	CbGpPWpGaD
Lisdexamfetamine—Vomiting—Budesonide—ulcerative colitis	0.00152	0.00183	CcSEcCtD
Lisdexamfetamine—Rash—Budesonide—ulcerative colitis	0.00151	0.00181	CcSEcCtD
Lisdexamfetamine—Dermatitis—Budesonide—ulcerative colitis	0.00151	0.00181	CcSEcCtD
Lisdexamfetamine—Convulsion—Prednisolone—ulcerative colitis	0.0015	0.00181	CcSEcCtD
Lisdexamfetamine—Headache—Budesonide—ulcerative colitis	0.0015	0.0018	CcSEcCtD
Lisdexamfetamine—Hypertension—Prednisolone—ulcerative colitis	0.0015	0.0018	CcSEcCtD
Lisdexamfetamine—Selegiline—ABCB1—ulcerative colitis	0.00148	0.0526	CrCbGaD
Lisdexamfetamine—Convulsion—Hydrocortisone—ulcerative colitis	0.00147	0.00177	CcSEcCtD
Lisdexamfetamine—Hypertension—Hydrocortisone—ulcerative colitis	0.00146	0.00176	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Azathioprine—ulcerative colitis	0.00146	0.00176	CcSEcCtD
Lisdexamfetamine—Angioedema—Triamcinolone—ulcerative colitis	0.00146	0.00175	CcSEcCtD
Lisdexamfetamine—Angioedema—Methylprednisolone—ulcerative colitis	0.00146	0.00175	CcSEcCtD
Lisdexamfetamine—Hallucination—Prednisone—ulcerative colitis	0.00144	0.00173	CcSEcCtD
Lisdexamfetamine—Anxiety—Hydrocortisone—ulcerative colitis	0.00144	0.00173	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Mesalazine—ulcerative colitis	0.00143	0.00172	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.00143	0.00172	CcSEcCtD
Lisdexamfetamine—Nausea—Budesonide—ulcerative colitis	0.00142	0.00171	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Prednisolone—ulcerative colitis	0.00142	0.0017	CcSEcCtD
Lisdexamfetamine—Dizziness—Azathioprine—ulcerative colitis	0.00141	0.0017	CcSEcCtD
Lisdexamfetamine—Asthenia—Mesalazine—ulcerative colitis	0.0014	0.00168	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.00138	0.00166	CcSEcCtD
Lisdexamfetamine—Convulsion—Triamcinolone—ulcerative colitis	0.00138	0.00166	CcSEcCtD
Lisdexamfetamine—Tachycardia—Prednisolone—ulcerative colitis	0.00138	0.00166	CcSEcCtD
Lisdexamfetamine—Convulsion—Methylprednisolone—ulcerative colitis	0.00138	0.00166	CcSEcCtD
Lisdexamfetamine—Hypertension—Triamcinolone—ulcerative colitis	0.00138	0.00166	CcSEcCtD
Lisdexamfetamine—Hypertension—Methylprednisolone—ulcerative colitis	0.00137	0.00165	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Prednisolone—ulcerative colitis	0.00137	0.00165	CcSEcCtD
Lisdexamfetamine—Vomiting—Azathioprine—ulcerative colitis	0.00136	0.00163	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.00136	0.00163	CcSEcCtD
Lisdexamfetamine—Eye disorder—Prednisone—ulcerative colitis	0.00135	0.00163	CcSEcCtD
Lisdexamfetamine—Anxiety—Methylprednisolone—ulcerative colitis	0.00135	0.00162	CcSEcCtD
Lisdexamfetamine—Tachycardia—Hydrocortisone—ulcerative colitis	0.00135	0.00162	CcSEcCtD
Lisdexamfetamine—Rash—Azathioprine—ulcerative colitis	0.00135	0.00162	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.00135	0.00162	CcSEcCtD
Lisdexamfetamine—Dermatitis—Azathioprine—ulcerative colitis	0.00135	0.00162	CcSEcCtD
Lisdexamfetamine—Skin disorder—Hydrocortisone—ulcerative colitis	0.00134	0.00162	CcSEcCtD
Lisdexamfetamine—Headache—Azathioprine—ulcerative colitis	0.00134	0.00161	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.00134	0.00161	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Mesalazine—ulcerative colitis	0.00133	0.0016	CcSEcCtD
Lisdexamfetamine—Dry mouth—Triamcinolone—ulcerative colitis	0.00133	0.0016	CcSEcCtD
Lisdexamfetamine—Angioedema—Betamethasone—ulcerative colitis	0.00132	0.00159	CcSEcCtD
Lisdexamfetamine—Angioedema—Dexamethasone—ulcerative colitis	0.00132	0.00159	CcSEcCtD
Lisdexamfetamine—Anorexia—Hydrocortisone—ulcerative colitis	0.00132	0.00159	CcSEcCtD
Lisdexamfetamine—Immune system disorder—Prednisone—ulcerative colitis	0.00131	0.00157	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.0013	0.00157	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.0013	0.00156	CcSEcCtD
Lisdexamfetamine—SLC6A2—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	0.00129	0.0092	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	0.00129	0.0092	CbGpPWpGaD
Lisdexamfetamine—Dizziness—Mesalazine—ulcerative colitis	0.00129	0.00155	CcSEcCtD
Lisdexamfetamine—Insomnia—Prednisolone—ulcerative colitis	0.00128	0.00154	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.00127	0.00153	CcSEcCtD
Lisdexamfetamine—Tachycardia—Triamcinolone—ulcerative colitis	0.00127	0.00153	CcSEcCtD
Lisdexamfetamine—Mental disorder—Prednisone—ulcerative colitis	0.00127	0.00153	CcSEcCtD
Lisdexamfetamine—Nausea—Azathioprine—ulcerative colitis	0.00127	0.00153	CcSEcCtD
Lisdexamfetamine—Tachycardia—Methylprednisolone—ulcerative colitis	0.00127	0.00153	CcSEcCtD
Lisdexamfetamine—Skin disorder—Methylprednisolone—ulcerative colitis	0.00126	0.00152	CcSEcCtD
Lisdexamfetamine—Malnutrition—Prednisone—ulcerative colitis	0.00126	0.00152	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.00126	0.00151	CcSEcCtD
Lisdexamfetamine—SLC6A2—Monoamine Transport—IL1B—ulcerative colitis	0.00126	0.00898	CbGpPWpGaD
Lisdexamfetamine—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.00126	0.00151	CcSEcCtD
Lisdexamfetamine—Convulsion—Betamethasone—ulcerative colitis	0.00125	0.00151	CcSEcCtD
Lisdexamfetamine—Convulsion—Dexamethasone—ulcerative colitis	0.00125	0.00151	CcSEcCtD
Lisdexamfetamine—Insomnia—Hydrocortisone—ulcerative colitis	0.00125	0.0015	CcSEcCtD
Lisdexamfetamine—Hypertension—Betamethasone—ulcerative colitis	0.00125	0.0015	CcSEcCtD
Lisdexamfetamine—Hypertension—Dexamethasone—ulcerative colitis	0.00125	0.0015	CcSEcCtD
Lisdexamfetamine—Vomiting—Mesalazine—ulcerative colitis	0.00124	0.00149	CcSEcCtD
Lisdexamfetamine—Anxiety—Dexamethasone—ulcerative colitis	0.00123	0.00148	CcSEcCtD
Lisdexamfetamine—Anxiety—Betamethasone—ulcerative colitis	0.00123	0.00148	CcSEcCtD
Lisdexamfetamine—Rash—Mesalazine—ulcerative colitis	0.00123	0.00147	CcSEcCtD
Lisdexamfetamine—Dermatitis—Mesalazine—ulcerative colitis	0.00123	0.00147	CcSEcCtD
Lisdexamfetamine—Headache—Mesalazine—ulcerative colitis	0.00122	0.00147	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Hydrocortisone—ulcerative colitis	0.00122	0.00146	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Hydrocortisone—ulcerative colitis	0.0012	0.00145	CcSEcCtD
Lisdexamfetamine—SLC18A2—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	0.00119	0.00852	CbGpPWpGaD
Lisdexamfetamine—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.00119	0.00144	CcSEcCtD
Lisdexamfetamine—Fatigue—Hydrocortisone—ulcerative colitis	0.00119	0.00143	CcSEcCtD
Lisdexamfetamine—Vision blurred—Prednisone—ulcerative colitis	0.00119	0.00143	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.00118	0.00142	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Betamethasone—ulcerative colitis	0.00118	0.00142	CcSEcCtD
Lisdexamfetamine—Insomnia—Triamcinolone—ulcerative colitis	0.00118	0.00142	CcSEcCtD
Lisdexamfetamine—Insomnia—Methylprednisolone—ulcerative colitis	0.00118	0.00141	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Triamcinolone—ulcerative colitis	0.00116	0.0014	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Betamethasone—ulcerative colitis	0.00116	0.00139	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Dexamethasone—ulcerative colitis	0.00116	0.00139	CcSEcCtD
Lisdexamfetamine—Agitation—Prednisone—ulcerative colitis	0.00116	0.00139	CcSEcCtD
Lisdexamfetamine—Nausea—Mesalazine—ulcerative colitis	0.00116	0.00139	CcSEcCtD
Lisdexamfetamine—Tachycardia—Dexamethasone—ulcerative colitis	0.00115	0.00139	CcSEcCtD
Lisdexamfetamine—Tachycardia—Betamethasone—ulcerative colitis	0.00115	0.00139	CcSEcCtD
Lisdexamfetamine—Angioedema—Prednisone—ulcerative colitis	0.00115	0.00139	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Triamcinolone—ulcerative colitis	0.00115	0.00138	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Methylprednisolone—ulcerative colitis	0.00114	0.00138	CcSEcCtD
Lisdexamfetamine—SLC6A3—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	0.00114	0.00815	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	0.00114	0.00815	CbGpPWpGaD
Lisdexamfetamine—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.00114	0.00137	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Betamethasone—ulcerative colitis	0.00114	0.00137	CcSEcCtD
Lisdexamfetamine—Anorexia—Betamethasone—ulcerative colitis	0.00113	0.00135	CcSEcCtD
Lisdexamfetamine—Anorexia—Dexamethasone—ulcerative colitis	0.00113	0.00135	CcSEcCtD
Lisdexamfetamine—Urticaria—Prednisolone—ulcerative colitis	0.00113	0.00135	CcSEcCtD
Lisdexamfetamine—Fatigue—Triamcinolone—ulcerative colitis	0.00112	0.00135	CcSEcCtD
Lisdexamfetamine—Fatigue—Methylprednisolone—ulcerative colitis	0.00112	0.00135	CcSEcCtD
Lisdexamfetamine—SLC6A3—Monoamine Transport—IL1B—ulcerative colitis	0.00112	0.00795	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.00111	0.00793	CbGpPWpGaD
Lisdexamfetamine—Urticaria—Hydrocortisone—ulcerative colitis	0.0011	0.00132	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Hydrocortisone—ulcerative colitis	0.00109	0.00131	CcSEcCtD
Lisdexamfetamine—Convulsion—Prednisone—ulcerative colitis	0.00109	0.00131	CcSEcCtD
Lisdexamfetamine—SLC18A2—Transmission across Chemical Synapses—CALM3—ulcerative colitis	0.00109	0.00778	CbGpPWpGaD
Lisdexamfetamine—Hypertension—Prednisone—ulcerative colitis	0.00109	0.00131	CcSEcCtD
Lisdexamfetamine—Anxiety—Prednisone—ulcerative colitis	0.00107	0.00129	CcSEcCtD
Lisdexamfetamine—Insomnia—Dexamethasone—ulcerative colitis	0.00107	0.00129	CcSEcCtD
Lisdexamfetamine—Insomnia—Betamethasone—ulcerative colitis	0.00107	0.00129	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.00107	0.00128	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Prednisolone—ulcerative colitis	0.00104	0.00125	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Dexamethasone—ulcerative colitis	0.00104	0.00125	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Betamethasone—ulcerative colitis	0.00104	0.00125	CcSEcCtD
Lisdexamfetamine—Urticaria—Triamcinolone—ulcerative colitis	0.00103	0.00124	CcSEcCtD
Lisdexamfetamine—Urticaria—Methylprednisolone—ulcerative colitis	0.00103	0.00124	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Triamcinolone—ulcerative colitis	0.00103	0.00124	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Prednisone—ulcerative colitis	0.00103	0.00124	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Betamethasone—ulcerative colitis	0.00103	0.00124	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Dexamethasone—ulcerative colitis	0.00103	0.00124	CcSEcCtD
Lisdexamfetamine—ADRA1B—LPA receptor mediated events—ADCY5—ulcerative colitis	0.00102	0.00729	CbGpPWpGaD
Lisdexamfetamine—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.00102	0.00123	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.00102	0.00123	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.00102	0.00123	CcSEcCtD
Lisdexamfetamine—Fatigue—Dexamethasone—ulcerative colitis	0.00102	0.00123	CcSEcCtD
Lisdexamfetamine—Fatigue—Betamethasone—ulcerative colitis	0.00102	0.00123	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Prednisone—ulcerative colitis	0.00101	0.00121	CcSEcCtD
Lisdexamfetamine—Tachycardia—Prednisone—ulcerative colitis	0.001	0.00121	CcSEcCtD
Lisdexamfetamine—Skin disorder—Prednisone—ulcerative colitis	0.001	0.0012	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Prednisone—ulcerative colitis	0.000995	0.0012	CcSEcCtD
Lisdexamfetamine—Asthenia—Hydrocortisone—ulcerative colitis	0.000993	0.00119	CcSEcCtD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000986	0.00703	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Dopaminergic Neurogenesis—STAT3—ulcerative colitis	0.000985	0.00702	CbGpPWpGaD
Lisdexamfetamine—Anorexia—Prednisone—ulcerative colitis	0.000981	0.00118	CcSEcCtD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.000975	0.00695	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	0.000975	0.00695	CbGpPWpGaD
Lisdexamfetamine—Hypersensitivity—Triamcinolone—ulcerative colitis	0.00096	0.00115	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000958	0.00115	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000947	0.00114	CcSEcCtD
Lisdexamfetamine—Urticaria—Dexamethasone—ulcerative colitis	0.000939	0.00113	CcSEcCtD
Lisdexamfetamine—Urticaria—Betamethasone—ulcerative colitis	0.000939	0.00113	CcSEcCtD
Lisdexamfetamine—Dizziness—Prednisolone—ulcerative colitis	0.000937	0.00113	CcSEcCtD
Lisdexamfetamine—Asthenia—Triamcinolone—ulcerative colitis	0.000935	0.00112	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Dexamethasone—ulcerative colitis	0.000934	0.00112	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Betamethasone—ulcerative colitis	0.000934	0.00112	CcSEcCtD
Lisdexamfetamine—Asthenia—Methylprednisolone—ulcerative colitis	0.000933	0.00112	CcSEcCtD
Lisdexamfetamine—Insomnia—Prednisone—ulcerative colitis	0.000931	0.00112	CcSEcCtD
Lisdexamfetamine—Dizziness—Hydrocortisone—ulcerative colitis	0.000915	0.0011	CcSEcCtD
Lisdexamfetamine—SLC6A2—Monoamine Transport—TNF—ulcerative colitis	0.000914	0.00651	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Dopaminergic Neurogenesis—TGFB1—ulcerative colitis	0.000913	0.00651	CbGpPWpGaD
Lisdexamfetamine—Dyspepsia—Prednisone—ulcerative colitis	0.000906	0.00109	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Prednisone—ulcerative colitis	0.000895	0.00108	CcSEcCtD
Lisdexamfetamine—Rash—Prednisolone—ulcerative colitis	0.000893	0.00107	CcSEcCtD
Lisdexamfetamine—Dermatitis—Prednisolone—ulcerative colitis	0.000892	0.00107	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000889	0.00107	CcSEcCtD
Lisdexamfetamine—Fatigue—Prednisone—ulcerative colitis	0.000887	0.00107	CcSEcCtD
Lisdexamfetamine—Headache—Prednisolone—ulcerative colitis	0.000887	0.00107	CcSEcCtD
Lisdexamfetamine—Constipation—Prednisone—ulcerative colitis	0.00088	0.00106	CcSEcCtD
Lisdexamfetamine—Vomiting—Hydrocortisone—ulcerative colitis	0.00088	0.00106	CcSEcCtD
Lisdexamfetamine—Rash—Hydrocortisone—ulcerative colitis	0.000872	0.00105	CcSEcCtD
Lisdexamfetamine—Dermatitis—Hydrocortisone—ulcerative colitis	0.000871	0.00105	CcSEcCtD
Lisdexamfetamine—Headache—Hydrocortisone—ulcerative colitis	0.000867	0.00104	CcSEcCtD
Lisdexamfetamine—Dizziness—Triamcinolone—ulcerative colitis	0.000861	0.00104	CcSEcCtD
Lisdexamfetamine—Dizziness—Methylprednisolone—ulcerative colitis	0.000859	0.00103	CcSEcCtD
Lisdexamfetamine—Asthenia—Betamethasone—ulcerative colitis	0.000848	0.00102	CcSEcCtD
Lisdexamfetamine—Asthenia—Dexamethasone—ulcerative colitis	0.000848	0.00102	CcSEcCtD
Lisdexamfetamine—Nausea—Prednisolone—ulcerative colitis	0.000841	0.00101	CcSEcCtD
Lisdexamfetamine—SLC18A2—Neuronal System—CALM3—ulcerative colitis	0.000836	0.00596	CbGpPWpGaD
Lisdexamfetamine—Vomiting—Triamcinolone—ulcerative colitis	0.000828	0.000996	CcSEcCtD
Lisdexamfetamine—Vomiting—Methylprednisolone—ulcerative colitis	0.000826	0.000994	CcSEcCtD
Lisdexamfetamine—Nausea—Hydrocortisone—ulcerative colitis	0.000822	0.000988	CcSEcCtD
Lisdexamfetamine—Rash—Triamcinolone—ulcerative colitis	0.000821	0.000988	CcSEcCtD
Lisdexamfetamine—Dermatitis—Triamcinolone—ulcerative colitis	0.000821	0.000987	CcSEcCtD
Lisdexamfetamine—Rash—Methylprednisolone—ulcerative colitis	0.000819	0.000985	CcSEcCtD
Lisdexamfetamine—Dermatitis—Methylprednisolone—ulcerative colitis	0.000819	0.000984	CcSEcCtD
Lisdexamfetamine—Urticaria—Prednisone—ulcerative colitis	0.000818	0.000983	CcSEcCtD
Lisdexamfetamine—Headache—Triamcinolone—ulcerative colitis	0.000816	0.000981	CcSEcCtD
Lisdexamfetamine—Headache—Methylprednisolone—ulcerative colitis	0.000814	0.000979	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Prednisone—ulcerative colitis	0.000814	0.000978	CcSEcCtD
Lisdexamfetamine—SLC6A3—Monoamine Transport—TNF—ulcerative colitis	0.000809	0.00577	CbGpPWpGaD
Lisdexamfetamine—Diarrhoea—Dexamethasone—ulcerative colitis	0.000809	0.000972	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Betamethasone—ulcerative colitis	0.000809	0.000972	CcSEcCtD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.000804	0.00573	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	0.000804	0.00573	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	0.000791	0.00564	CbGpPWpGaD
Lisdexamfetamine—Dizziness—Dexamethasone—ulcerative colitis	0.000782	0.00094	CcSEcCtD
Lisdexamfetamine—Dizziness—Betamethasone—ulcerative colitis	0.000782	0.00094	CcSEcCtD
Lisdexamfetamine—Nausea—Triamcinolone—ulcerative colitis	0.000774	0.00093	CcSEcCtD
Lisdexamfetamine—Nausea—Methylprednisolone—ulcerative colitis	0.000772	0.000928	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Prednisone—ulcerative colitis	0.000758	0.000912	CcSEcCtD
Lisdexamfetamine—Vomiting—Betamethasone—ulcerative colitis	0.000751	0.000904	CcSEcCtD
Lisdexamfetamine—Vomiting—Dexamethasone—ulcerative colitis	0.000751	0.000904	CcSEcCtD
Lisdexamfetamine—Rash—Betamethasone—ulcerative colitis	0.000745	0.000896	CcSEcCtD
Lisdexamfetamine—Rash—Dexamethasone—ulcerative colitis	0.000745	0.000896	CcSEcCtD
Lisdexamfetamine—Dermatitis—Betamethasone—ulcerative colitis	0.000745	0.000895	CcSEcCtD
Lisdexamfetamine—Dermatitis—Dexamethasone—ulcerative colitis	0.000745	0.000895	CcSEcCtD
Lisdexamfetamine—Headache—Betamethasone—ulcerative colitis	0.00074	0.00089	CcSEcCtD
Lisdexamfetamine—Headache—Dexamethasone—ulcerative colitis	0.00074	0.00089	CcSEcCtD
Lisdexamfetamine—Asthenia—Prednisone—ulcerative colitis	0.000739	0.000888	CcSEcCtD
Lisdexamfetamine—ADRA1B—Calcium Regulation in the Cardiac Cell—CALM3—ulcerative colitis	0.000717	0.00511	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	0.000712	0.00508	CbGpPWpGaD
Lisdexamfetamine—Diarrhoea—Prednisone—ulcerative colitis	0.000704	0.000847	CcSEcCtD
Lisdexamfetamine—Nausea—Betamethasone—ulcerative colitis	0.000702	0.000844	CcSEcCtD
Lisdexamfetamine—Nausea—Dexamethasone—ulcerative colitis	0.000702	0.000844	CcSEcCtD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.000689	0.00491	CbGpPWpGaD
Lisdexamfetamine—Dizziness—Prednisone—ulcerative colitis	0.000681	0.000818	CcSEcCtD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.000656	0.00468	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	0.000656	0.00468	CbGpPWpGaD
Lisdexamfetamine—Vomiting—Prednisone—ulcerative colitis	0.000654	0.000787	CcSEcCtD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—CALM3—ulcerative colitis	0.00065	0.00464	CbGpPWpGaD
Lisdexamfetamine—Rash—Prednisone—ulcerative colitis	0.000649	0.00078	CcSEcCtD
Lisdexamfetamine—Dermatitis—Prednisone—ulcerative colitis	0.000648	0.00078	CcSEcCtD
Lisdexamfetamine—Headache—Prednisone—ulcerative colitis	0.000645	0.000775	CcSEcCtD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.000629	0.00449	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—LPA receptor mediated events—RELA—ulcerative colitis	0.000617	0.0044	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—G alpha (q) signalling events—GHRL—ulcerative colitis	0.000617	0.0044	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Calcium Regulation in the Cardiac Cell—ADRB2—ulcerative colitis	0.000613	0.00437	CbGpPWpGaD
Lisdexamfetamine—Nausea—Prednisone—ulcerative colitis	0.000611	0.000735	CcSEcCtD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	0.000607	0.00433	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Neuronal System—ADCY5—ulcerative colitis	0.000606	0.00432	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.000605	0.00431	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.000592	0.00422	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—LPA receptor mediated events—CXCL8—ulcerative colitis	0.000582	0.00415	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	0.000581	0.00414	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.000581	0.00414	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	0.000552	0.00393	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.000539	0.00384	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—LPA receptor mediated events—MMP9—ulcerative colitis	0.000526	0.00375	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—CXCR1—ulcerative colitis	0.000525	0.00374	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.000521	0.00371	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—LPA receptor mediated events—NFKB1—ulcerative colitis	0.000521	0.00371	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Calcium Regulation in the Cardiac Cell—ADCY5—ulcerative colitis	0.00052	0.00371	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000507	0.00361	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—CALM3—ulcerative colitis	0.000498	0.00355	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	0.000472	0.00336	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—CCL20—ulcerative colitis	0.000461	0.00328	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.000446	0.00318	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—SLC-mediated transmembrane transport—ALB—ulcerative colitis	0.00043	0.00307	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—CXCR2—ulcerative colitis	0.000411	0.00293	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000409	0.00291	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	0.000409	0.00291	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000395	0.00281	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—CCR6—ulcerative colitis	0.000386	0.00275	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	0.000362	0.00258	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—ADCY5—ulcerative colitis	0.000361	0.00258	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	0.000349	0.00249	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—PTGER4—ulcerative colitis	0.00034	0.00242	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000338	0.00241	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—AMPK Signaling—TP53—ulcerative colitis	0.000336	0.0024	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	0.000326	0.00232	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—GHRL—ulcerative colitis	0.000311	0.00222	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000297	0.00211	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—NRF2 pathway—TGFB1—ulcerative colitis	0.000291	0.00207	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—SLC-mediated transmembrane transport—ALB—ulcerative colitis	0.000289	0.00206	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CXCR1—ulcerative colitis	0.000269	0.00192	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CCL20—ulcerative colitis	0.00026	0.00186	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—ADRB2—ulcerative colitis	0.000258	0.00184	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—NRF2 pathway—TGFB1—ulcerative colitis	0.000257	0.00183	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—SLC-mediated transmembrane transport—ALB—ulcerative colitis	0.000256	0.00183	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—GNA12—ulcerative colitis	0.000245	0.00175	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.000242	0.00172	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CCL20—ulcerative colitis	0.000236	0.00169	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	0.000235	0.00168	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000232	0.00165	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—GNA12—ulcerative colitis	0.000222	0.00158	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	0.000219	0.00156	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—ALB—ulcerative colitis	0.000219	0.00156	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CCR6—ulcerative colitis	0.000218	0.00156	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CXCR2—ulcerative colitis	0.000211	0.0015	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	0.000208	0.00148	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CCR6—ulcerative colitis	0.000198	0.00141	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	0.000194	0.00139	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—SEL1L—ulcerative colitis	0.000193	0.00138	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000192	0.00137	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—GHRL—ulcerative colitis	0.000176	0.00125	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PTGER4—ulcerative colitis	0.000174	0.00124	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000163	0.00116	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—GHRL—ulcerative colitis	0.00016	0.00114	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CXCR1—ulcerative colitis	0.000159	0.00113	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CALM3—ulcerative colitis	0.000155	0.0011	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—ALB—ulcerative colitis	0.000147	0.00105	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000146	0.00104	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CCL20—ulcerative colitis	0.00014	0.000996	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—ADRB2—ulcerative colitis	0.000132	0.000942	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—GNA12—ulcerative colitis	0.000131	0.000936	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—ALB—ulcerative colitis	0.00013	0.000929	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CXCR2—ulcerative colitis	0.000124	0.000887	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—CXCL8—ulcerative colitis	0.000124	0.000887	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	0.000124	0.000884	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000124	0.000881	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CCR6—ulcerative colitis	0.000117	0.000834	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—ADCY5—ulcerative colitis	0.000112	0.0008	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—MAML2—ulcerative colitis	0.000111	0.000791	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PTGER4—ulcerative colitis	0.000103	0.000735	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—GHRL—ulcerative colitis	9.43e-05	0.000673	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CALM3—ulcerative colitis	9.14e-05	0.000651	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—RIPK2—ulcerative colitis	9e-05	0.000642	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ADRB2—ulcerative colitis	7.81e-05	0.000557	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—JAK2—ulcerative colitis	7.7e-05	0.000549	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CXCL8—ulcerative colitis	7.03e-05	0.000501	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—JAK2—ulcerative colitis	7e-05	0.000499	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—IL2—ulcerative colitis	6.72e-05	0.000479	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ADCY5—ulcerative colitis	6.63e-05	0.000473	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CXCL8—ulcerative colitis	6.38e-05	0.000455	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—IL2—ulcerative colitis	6.1e-05	0.000435	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—JAK2—ulcerative colitis	4.13e-05	0.000295	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—RELA—ulcerative colitis	4e-05	0.000285	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CXCL8—ulcerative colitis	3.77e-05	0.000269	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—IL2—ulcerative colitis	3.6e-05	0.000257	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—IL6—ulcerative colitis	3.59e-05	0.000256	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—MMP9—ulcerative colitis	3.41e-05	0.000243	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NFKB1—ulcerative colitis	3.38e-05	0.000241	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—STAT3—ulcerative colitis	3.03e-05	0.000216	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TGFB1—ulcerative colitis	2.81e-05	0.0002	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TP53—ulcerative colitis	2.31e-05	0.000165	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—IL6—ulcerative colitis	2.12e-05	0.000151	CbGpPWpGaD
